Bleomycin sulfate in the treatment of mosaic plantar verrucae: a follow-up study.
In this report, the authors will supplement research performed in 1989 by Sollitto, Napoli, and Gazivoda on the use of intralesional bleomycin for the treatment of verrucae. With various alterations of technique, their original success rate of 32.2% was improved to 65.4%. Thus, bleomycin is a very effective first line treatment for multiple verrucae, particularly of the mosaic variety. An association is also made between patients with pedal hyperhidrosis and the occurrence of multiple verrucae, notably lesions that prove recalcitrant to initial therapy.
Sollitto
R J
RJ
Saddle Brook Surgicenter, New Jersey 07663, USA.
Pizzano
D M
DM
D000293:Adolescent; D000328:Adult; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D005534:Foot Diseases / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006945:Hyperhidrosis / Q000150:complications; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D027383:Papillomaviridae / Q000145:classification; D014860:Warts / Q000188:drug therapy* / Q000209:etiology / Q000821:virology
D001761:Bleomycin